For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period.
The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Sanger Sequencing Service. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Sanger Sequencing Service market.
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3' carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.
Key Features:
The report on Sanger Sequencing Service market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Sanger Sequencing Service market. It may include historical data, market Segmentation by Type (e.g., PCR Products, Plasmid DNA), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Sanger Sequencing Service market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Sanger Sequencing Service market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Sanger Sequencing Service industry. This include advancements in Sanger Sequencing Service technology, Sanger Sequencing Service new entrants, Sanger Sequencing Service new investment, and other innovations that are shaping the future of Sanger Sequencing Service.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Sanger Sequencing Service market. It includes factors influencing customer ' purchasing decisions, preferences for Sanger Sequencing Service product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Sanger Sequencing Service market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Sanger Sequencing Service market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Sanger Sequencing Service market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Sanger Sequencing Service industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Sanger Sequencing Service market.
Market Segmentation:
Sanger Sequencing Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- PCR Products
- Plasmid DNA
- Bacterial Artificial Chromosomes (BAC)
- Others
Segmentation by application
- Research Institutions
- Biotech Companies
- Universities and Colleges
- Hospitals and Clinics
- Pharmaceutical Companies
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Thermo Fisher
- Azenta
- Eurofins Scientific
- LGC Biosearch Technologies
- Fasteris
- QuintaraBio
- Laragen
- Microsynth
- Nucleics
- GenScript Biotech
- CeMIA
- StarSEQ
- Source BioScience
- Guangzhou Life Technologies DaAn
- SciGenom Labs
- Psomagen
- Tsingke Biotechnology
- GenHunter
- CD Genomics
- Shanghai Personalbio Technology
- Suzhou Hongxun Biotechnologies
- Guangzhou IGE Biotechnology